A recent study suggests that individuals who come off new slimming jabs like Mounjaro or Wegovy may regain reduced body mass at a significantly accelerated pace than those who halt traditional lifestyle programs.
Research printed in a major medical journal demonstrates that while overweight people often shed a large proportion of their body weight while undergoing treatment, the mass is regained at an estimated rate of nearly a kilo each month after stopping.
"Individuals purchasing these drugs should be informed of the potential of quick weight regain when the therapy ends," stated lead investigator Dr. Susan Jebb.
Such speed of regain implies a return to original weight within about one and a half years.
Comparing Treatments
The analysis, which examined dozens of trials involving over 9,000 of patients, contrasted the results of GLP-1 agonists with other pills.
Researchers note that people who lose weight through diet and exercise generally experience a less rapid weight regain—perhaps 100 grams monthly—post-intervention.
The Reason for the Fast Rebound
Experts suggest the way of the drugs accounts for the accelerated weight return.
GLP-1 drugs mimic a body's own chemical called glucagon-like peptide-1, which controls hunger.
"Artificially providing GLP-1 levels several times higher than normal could lead to the body to generate a reduced amount of its own natural hormone, and may also lessen sensitivity to its actions," said Dr. Adam Collins, a dietetics specialist.
"Withdrawal of this medication leads to hunger is uncontrolled, making overeating a significant risk."
A Chronic Disease?
The NHS recommend the injections for people with obesity-related medical conditions, alongside prescribed lifestyle changes.
Many experts contend that, considering the significant potential of relapse, the treatment should be considered ongoing.
This opinion is supported by drug manufacturers, who note that the findings "underscore the chronic nature of excess weight," comparing it to managing diseases like high blood pressure.
Patient Testimonies
Individuals who have discontinued the medication explain a intense resurgence of hunger.
"It felt as if something flipping and I was suddenly extremely hungry," described an individual.
This challenge is compounded if users have not established sustainable lifestyle or habit modifications during therapy.
Growing Interest
Survey data show that a significant number of adults in the UK have used weight-loss jabs in the last 12 months, with desire being substantial.
- Adoption is greater among women than males.
- The middle-aged age group shows the greatest usage rates.
- Many access the drugs through private healthcare rather than the NHS.
In conclusion, experts stress that while these medications are powerful tools for shedding pounds, they are not a permanent fix and lasting health benefits relies on ongoing lifestyle management.
